Gsa Capital Partners LLP Mannkind Corp Transaction History
Gsa Capital Partners LLP
- $1.43 Billion
- Q2 2025
A detailed history of Gsa Capital Partners LLP transactions in Mannkind Corp stock. As of the latest transaction made, Gsa Capital Partners LLP holds 233,558 shares of MNKD stock, worth $854,822. This represents 0.06% of its overall portfolio holdings.
Number of Shares
233,558
Previous 44,206
428.34%
Holding current value
$854,822
Previous $222,000
293.69%
% of portfolio
0.06%
Previous 0.02%
Shares
19 transactions
Others Institutions Holding MNKD
# of Institutions
248Shares Held
161MCall Options Held
1.24MPut Options Held
179K-
Black Rock Inc. New York, NY22.6MShares$82.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$66.5 Million0.0% of portfolio
-
State Street Corp Boston, MA10.7MShares$39.3 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA7.62MShares$27.9 Million0.0% of portfolio
-
Nitorum Capital, L.P. New York, NY7.01MShares$25.7 Million4.77% of portfolio
About MANNKIND CORP
- Ticker MNKD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 257,338,000
- Market Cap $942M
- Description
- MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...